Cargando…

Editorial: Systemic implications of Alzheimer's disease

Detalles Bibliográficos
Autores principales:	Cortes, Constanza J., Thyfault, John P., Wilkins, Heather M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242176/ https://www.ncbi.nlm.nih.gov/pubmed/37287872 http://dx.doi.org/10.3389/fnagi.2023.1219987

Ejemplares similares

Editorial: Improving memory deficits in Alzheimer's disease
por: Wang, Fushun, et al.
Publicado: (2022)

Editorial: Progress of Translational Medicine in Alzheimer's Disease
por: Zhang, Can, et al.
Publicado: (2022)

Editorial: Insights in Alzheimer's disease and related dementias
por: Ibáñez, Agustín, et al.
Publicado: (2022)

Editorial: Insights in Alzheimer's disease and related dementias: 2022
por: Ibáñez, Agustín, et al.
Publicado: (2023)

Editorial: Neuroimaging Biomarkers and Cognition in Alzheimer's Disease Spectrum
por: Chen, Jiu, et al.
Publicado: (2022)

Editorial: Methods and applications in Alzheimer's disease and related dementias
por: Yogi, Alvaro, et al.
Publicado: (2022)

Editorial: How does exercise modify the course of Alzheimer's disease?
por: Arciero, Paul J., et al.
Publicado: (2023)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

The role of ADAM10 in astrocytes: Implications for Alzheimer’s disease
por: Elsworthy, Richard J., et al.
Publicado: (2022)

Editorial: Imaging of the blood-brain barrier in Alzheimer's disease and related disorders
por: Uchida, Yuto, et al.
Publicado: (2023)

Editorial: Infection, inflammation, and neurodegeneration: A critical path to Alzheimer's disease, Volume II
por: Mancuso, Roberta, et al.
Publicado: (2022)

Editorial: Expert opinions on the relationship between microglia, glia, and Alzheimer's disease: 2022
por: Gomez-Arboledas, Angela, et al.
Publicado: (2023)

Editorial: Metabolic signaling dysregulation and cognitive impairments in aging and Alzheimer's disease, volume II
por: Ma, Tao, et al.
Publicado: (2023)

Editorial: Alzheimer-related affective symptoms – mechanism and treatment
por: Nitzan, Keren, et al.
Publicado: (2023)

Editorial: Non-coding RNA in Alzheimer's pathology and diagnosis
por: Kalra, Rajkumar Singh, et al.
Publicado: (2022)

Editorial: Molecular mechanisms of Alzheimer’s disease: From top to bottom
por: Mello-Carpes, Pâmela B., et al.
Publicado: (2022)

Editorial: The crosstalk of different mechanisms in cognitive impairment associated with aging, Alzheimer's disease, and related dementias
por: Giménez-Llort, Lydia
Publicado: (2023)

Editorial: Translational Advances in Alzheimer's, Parkinson's, and Other Neurodegenerative Dementias
por: Jiang, Jiehui, et al.
Publicado: (2022)

Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer’s Disease
por: Shen, Zhiwei, et al.
Publicado: (2018)

Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer’s Disease
por: Xu, Yi-Jun, et al.
Publicado: (2022)

Editorial: Peripheral immune system and neurodegenerative disease
por: Zhang, Ke, et al.
Publicado: (2022)

Editorial: Metabolism in Alzheimer's Disease
por: Morris, Jill K., et al.
Publicado: (2022)

Editorial: New developments in understanding brain and cerebromicrovascular aging: Toward prevention of vascular cognitive impairment and Alzheimer's disease
por: Sanford, Madison, et al.
Publicado: (2022)

The Rhesus Macaque as a Translational Model for Neurodegeneration and Alzheimer’s Disease
por: Stonebarger, Gail A., et al.
Publicado: (2021)

Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease
por: Shade, Ronnie D., et al.
Publicado: (2022)

Editorial: Additive or synergistic impacts of sleep, circadian rhythm disturbances and other modifiable risk factors on established and novel plasma biomarkers of Alzheimer's disease pathology
por: Bubu, Omonigho M., et al.
Publicado: (2023)

Sex Differences in Large Artery Stiffness: Implications for Cerebrovascular Dysfunction and Alzheimer’s Disease
por: Kehmeier, Mackenzie N., et al.
Publicado: (2021)

Understanding How Physical Exercise Improves Alzheimer’s Disease: Cholinergic and Monoaminergic Systems
por: Zong, Boyi, et al.
Publicado: (2022)

Editorial: Role of Senescence in Neurodegenerative Diseases
por: Tüzer, Ferit, et al.
Publicado: (2022)

Redox signaling and metabolism in Alzheimer's disease
por: Holubiec, M. I., et al.
Publicado: (2022)

Editorial: Measurable brain and cognitive reserve: The implication of neuroimaging biomarkers in the normal aging process
por: Huang, Chu-Chung, et al.
Publicado: (2022)

Alzheimer’s disease: an axonal injury disease?
por: Dan, Liang, et al.
Publicado: (2023)

Editorial: Translational advances in Alzheimer's, Parkinson's, and other dementia: Molecular mechanisms, biomarkers, diagnosis, and therapies, volume II
por: Jiang, Jiehui, et al.
Publicado: (2022)

Editorial: Redox regulation and signaling in neurodegenerative diseases
por: Holubiec, M. I., et al.
Publicado: (2023)

Tau kinetics in Alzheimer's disease
por: Hier, Daniel B., et al.
Publicado: (2022)

Editorial: Post-Acute Sequelae of COVID-19 infection (PASC): Implications for geriatric and neurological care
por: Ng, Ted Kheng Siang, et al.
Publicado: (2023)

Editorial: Horizons in aging, immune system and infectious diseases
por: Camell, Christina, et al.
Publicado: (2022)

c-Abl tyrosine kinase down-regulation as target for memory improvement in Alzheimer’s disease
por: León, Rilda, et al.
Publicado: (2023)

Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
por: Wang, Zhifu, et al.
Publicado: (2023)

Editorial: Environmental clues to brain disease
por: Giannoni, Patrizia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t6gs9rl8e8vo1ql353qmc8fu5s